New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareGHK vs Follistatin 344

GHK vs Follistatin 344

Side-by-side comparison of key properties, dosing, and research.

Skin & CosmeticAnti-Aging & Longevity
GHK
Anabolic & IGF
Follistatin 344
Summary
GHK is the natural tripeptide (Gly-His-Lys) released from human albumin that activates tissue remodeling, collagen synthesis, and anti-aging gene expression. The copper-free form is the biological signaling molecule; it chelates copper in tissue to form GHK-Cu but also has independent biological activity.
Follistatin 344 is a recombinant form of the endogenous follistatin protein. It inhibits myostatin and activin — the primary negative regulators of muscle growth — potentially removing the genetic ceiling on muscle development. It is one of the most theoretically powerful anabolic compounds but is experimental with limited human data.
Half-Life
Extremely short as free peptide; tissue binding extends local effects
~24–36 hours
Admin Route
SubQ, Topical, Oral
SubQ, IM
Research
Typical Dose
100–500 mcg
100 mcg
Frequency
Daily or 5x per week
Once daily
Key Benefits
  • Stimulates collagen and extracellular matrix synthesis
  • Activates tissue repair gene expression programs
  • Anti-aging: reverses 57% of age-related gene changes
  • Antioxidant and anti-inflammatory
  • Wound healing and skin barrier repair
  • Improves skin laxity, texture, and radiance
  • Neuroprotective (stimulates NGF, BDNF)
  • Anti-fibrotic in liver and lung models
  • Inhibits myostatin — removes muscle growth ceiling
  • Significant increases in muscle mass and strength
  • Reduces fat mass
  • Promotes bone density
  • May stimulate hair follicle cycling
  • Anti-fibrotic effects in muscle tissue
  • Synergistic with IGF-1 and other anabolic peptides
Side Effects
  • Excellent safety profile (naturally occurring peptide)
  • Rare: mild injection site reaction (SC)
  • No significant adverse effects identified in research
  • Muscle soreness (from rapid hypertrophy)
  • Potential reproductive effects (activin inhibition)
  • Unknown long-term safety profile
  • Possible esophageal effects at high doses (animal data)
Stacks With